Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1961 1
1977 1
1979 1
1981 2
1982 3
1985 1
1990 2
1992 2
1993 3
1994 3
1995 1
1996 2
1997 1
1998 2
2002 4
2003 2
2004 3
2005 3
2006 1
2007 5
2008 1
2009 1
2010 5
2011 4
2012 1
2013 5
2014 4
2015 2
2016 3
2017 5
2018 4
2019 2
2020 2
2021 3
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic biliopathy. Persistent growth failure, symptomatic and recurrent hepatic encephalopathy, impaired quality of lif …
Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hyper …
Portal hypertension and its management in children.
Grammatikopoulos T, McKiernan PJ, Dhawan A. Grammatikopoulos T, et al. Arch Dis Child. 2018 Feb;103(2):186-191. doi: 10.1136/archdischild-2015-310022. Epub 2017 Aug 16. Arch Dis Child. 2018. PMID: 28814423 Review.
National Consensus on Portal Hypertension Management in Indonesia.
Kurniawan J, Sulaiman AS, Lesmana CRA, Bayupurnama P, Bestari MB, Akil F, Gani RA, Hasan I. Kurniawan J, et al. Acta Med Indones. 2022 Apr;54(2):324-346. Acta Med Indones. 2022. PMID: 35818657 Free article.
Portal hypertension is a clinical syndrome that consists of hypersplenism, ascites, gastroesophageal varices, and encephalopathy. ...
Portal hypertension is a clinical syndrome that consists of hypersplenism, ascites, gastroesophageal varices, and encephalopathy. ...
Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Vassilakopoulos TP. Kalpadakis C, et al. Best Pract Res Clin Haematol. 2018 Mar;31(1):65-72. doi: 10.1016/j.beha.2017.10.011. Epub 2017 Nov 7. Best Pract Res Clin Haematol. 2018. PMID: 29452668 Review.
Since there is no prospective randomized trials to establish the best treatment approach, decision on therapeutic management should be based on the available retrospective series. ...More than 90% of the patients present quick amelioration of splenomegaly related symptoms …
Since there is no prospective randomized trials to establish the best treatment approach, decision on therapeutic management should b …
Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method.
Gao TM, Zhou J, Xiang XX, Jin SJ, Qian JJ, Zhang C, Zhou BH, Tang H, Bai DS, Jiang GQ. Gao TM, et al. J Gastroenterol. 2023 May;58(5):503-512. doi: 10.1007/s00535-023-01982-z. Epub 2023 Mar 21. J Gastroenterol. 2023. PMID: 36943530
BACKGROUND: Liver cirrhosis is the highest risk factor for hepatocellular carcinoma (HCC) worldwide. However, etiological therapy is the only option in cirrhosis patients to decrease the HCC risk. ...RESULTS: According to the method of therapy, patients were divided …
BACKGROUND: Liver cirrhosis is the highest risk factor for hepatocellular carcinoma (HCC) worldwide. However, etiological therapy is …
Current approaches to the treatment and management of chronic lymphocytic leukaemia.
Montserrat E, Rozman C. Montserrat E, et al. Drugs. 1994;47 Suppl 6:1-9. doi: 10.2165/00003495-199400476-00003. Drugs. 1994. PMID: 7525184 Review.
New agents such as fludarabine and 2-chlorodeoxyadenosine are already the treatment of choice for patients failing standard therapies, and their role as front-line therapy is being investigated in randomised trials. Whatever the treatment used, however, cure is rare …
New agents such as fludarabine and 2-chlorodeoxyadenosine are already the treatment of choice for patients failing standard therapies …
Minimally invasive treatment of cirrhotic secondary hypersplenism with high-intensity focused ultrasound.
Zhang X, Tang S, Huang G, Xu Z, Feng C, Yan G, He S. Zhang X, et al. Sci Rep. 2022 Nov 30;12(1):20700. doi: 10.1038/s41598-022-24416-x. Sci Rep. 2022. PMID: 36450808 Free PMC article.
From October 2019 to May 2021, eleven cases of patients with cirrhotic secondary hypersplenism were enrolled. The blood counts, liver function tests and abdominal ultrasound and/or MRI scans of all patients were closely evaluated. ...This series suggested that HIFU is an e …
From October 2019 to May 2021, eleven cases of patients with cirrhotic secondary hypersplenism were enrolled. The blood counts, liver …
Chronic hepatitis C-associated thrombocytopenia: aetiology and management.
Fouad YM. Fouad YM. Trop Gastroenterol. 2013 Apr-Jun;34(2):58-67. doi: 10.7869/tg.2012.99. Trop Gastroenterol. 2013. PMID: 24377151 Review.
Therapeutic options include pharmacological and non-pharmacological therapies. This review summarizes the available data on these therapeutic options....
Therapeutic options include pharmacological and non-pharmacological therapies. This review summarizes the available data on th …
Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage.
Pavel V, Scharf G, Mester P, Krauss LU, Gülow K, Mehrl A, Müller M, Schmid S. Pavel V, et al. BMC Gastroenterol. 2023 May 24;23(1):180. doi: 10.1186/s12876-023-02808-1. BMC Gastroenterol. 2023. PMID: 37226088 Free PMC article.
BACKGROUND: Partial splenic embolization (PSE) is a non-surgical procedure which was initially used to treat hypersplenism. Furthermore, partial splenic embolization can be used for the treatment of different conditions, including gastroesophageal variceal hemorrhage. ...C …
BACKGROUND: Partial splenic embolization (PSE) is a non-surgical procedure which was initially used to treat hypersplenism. Furthermo …
Chronic lymphocytic leukaemia treatment.
Montserrat E, Rozman C. Montserrat E, et al. Blood Rev. 1993 Sep;7(3):164-75. doi: 10.1016/0268-960x(93)90003-m. Blood Rev. 1993. PMID: 8241831 Review.
These agents are already the treatment of choice for patients failing standard therapies and its role as front-line therapy is being investigated in randomized trials. Whatever the treatment used, however, cure is rarely achieved. A number of situations (e.g. autoim …
These agents are already the treatment of choice for patients failing standard therapies and its role as front-line therapy is …
84 results